Women's lschemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)

Abstract

The WARRIOR trial is a multicenter, prospective, randomized, blinded outcome evaluation (PROBE design) evaluating intensive medical therapy vs usual care in 4,422 symptomatic women with ischemia but no obstructive CAD. The study aims to determine whether an intensive medication treatment strategy to modify risk factors in women with chest pain and/or abnormal stress tests, but non-obstructed coronary arteries will reduce their likelihood of dying, having a heart attack, stroke or being hospitalized. This project will activate 50-125 recruitment sites from across the US to enroll and follow these women for up to three years to assess adverse outcomes.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2021
Accession Number
AD1154891

Entities

People

  • Carl J Pepine
  • Eileen M Handberg
  • Margaret Chin-tzu Lo
  • Rhonda Cooper-dehoff

Organizations

  • University of Florida

Tags

DTIC Thesaurus Topics

  • Active Duty
  • Cardiology
  • Cardiovascular Diseases
  • Clinical Trials
  • Computer Programming
  • Contracts
  • Data Management
  • Department Of Defense
  • Diseases And Disorders
  • Health
  • Health Services
  • Heart Diseases
  • Heart Failure
  • Hygiene
  • Information Science
  • Institutional Review Board
  • Management Personnel
  • Medical Personnel
  • Myocardial Ischemia
  • Patient Care
  • Public Health
  • Risk Factors
  • Social Media
  • Therapy
  • Training

Fields of Study

  • Medicine

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Neurotrauma and Rehabilitation Medicine.
  • Oncology and Biomarker-Based Cancer Detection.